ValuEngine lowered shares of Intuitive Surgical (NASDAQ:ISRG) from a hold rating to a sell rating in a research report released on Friday.
Several other research analysts have also issued reports on the stock. Piper Jaffray Companies raised shares of Intuitive Surgical from a neutral rating to an overweight rating and set a $600.00 price target for the company in a research report on Tuesday, October 9th. Wells Fargo & Co upped their price objective on shares of Intuitive Surgical from $575.00 to $635.00 and gave the stock an outperform rating in a research note on Wednesday, September 12th. BidaskClub cut shares of Intuitive Surgical from a strong-buy rating to a buy rating in a research note on Wednesday, August 22nd. Cantor Fitzgerald reaffirmed a buy rating and set a $620.00 price objective on shares of Intuitive Surgical in a research note on Friday, October 19th. Finally, Royal Bank of Canada reaffirmed a hold rating and set a $560.00 price objective on shares of Intuitive Surgical in a research note on Friday, October 19th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. The stock has an average rating of Buy and an average price target of $556.01.
Shares of ISRG traded down $27.40 during trading hours on Friday, reaching $491.69. 902,678 shares of the company traded hands, compared to its average volume of 701,330. The firm has a market capitalization of $59.28 billion, a P/E ratio of 68.39, a P/E/G ratio of 3.76 and a beta of 1.03. Intuitive Surgical has a 1-year low of $359.75 and a 1-year high of $581.12.
Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 18th. The medical equipment provider reported $2.83 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.66 by $0.17. Intuitive Surgical had a net margin of 22.31% and a return on equity of 18.79%. The firm had revenue of $920.90 million during the quarter, compared to analyst estimates of $916.22 million. During the same quarter in the prior year, the business posted $2.77 earnings per share. The company’s quarterly revenue was up 14.0% compared to the same quarter last year. Equities research analysts predict that Intuitive Surgical will post 9.52 earnings per share for the current year.
In other Intuitive Surgical news, EVP David J. Rosa sold 32,500 shares of the firm’s stock in a transaction that occurred on Tuesday, October 23rd. The shares were sold at an average price of $500.86, for a total value of $16,277,950.00. Following the transaction, the executive vice president now directly owns 44,208 shares of the company’s stock, valued at $22,142,018.88. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, COO Salvatore Brogna sold 2,090 shares of the firm’s stock in a transaction that occurred on Monday, December 3rd. The shares were sold at an average price of $541.88, for a total transaction of $1,132,529.20. Following the completion of the transaction, the chief operating officer now directly owns 2,049 shares in the company, valued at $1,110,312.12. The disclosure for this sale can be found here. Insiders have sold 72,491 shares of company stock worth $37,767,784 over the last three months. 2.20% of the stock is owned by insiders.
A number of hedge funds have recently made changes to their positions in the business. CENTRAL TRUST Co boosted its stake in Intuitive Surgical by 26.4% in the third quarter. CENTRAL TRUST Co now owns 460 shares of the medical equipment provider’s stock valued at $264,000 after acquiring an additional 96 shares during the last quarter. Rafferty Asset Management LLC raised its holdings in Intuitive Surgical by 2.8% in the third quarter. Rafferty Asset Management LLC now owns 3,571 shares of the medical equipment provider’s stock worth $2,050,000 after purchasing an additional 96 shares during the period. Securian Asset Management Inc raised its holdings in Intuitive Surgical by 0.9% in the second quarter. Securian Asset Management Inc now owns 11,795 shares of the medical equipment provider’s stock worth $5,644,000 after purchasing an additional 100 shares during the period. Utah Retirement Systems raised its holdings in Intuitive Surgical by 0.5% in the third quarter. Utah Retirement Systems now owns 20,881 shares of the medical equipment provider’s stock worth $11,986,000 after purchasing an additional 100 shares during the period. Finally, Mutual of America Capital Management LLC raised its holdings in Intuitive Surgical by 0.7% in the third quarter. Mutual of America Capital Management LLC now owns 14,686 shares of the medical equipment provider’s stock worth $8,430,000 after purchasing an additional 102 shares during the period. 84.31% of the stock is currently owned by hedge funds and other institutional investors.
About Intuitive Surgical
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Recommended Story: Earnings Reports
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.